MLchartDataset catalogue

Jelmyto

Term · Oncology and biomedicine · MLC-T-ONC-004580

A drug that contains the active ingredient mitomycin, which comes from the bacterium Streptomyces, and is used to treat adults with a certain type of urothelial cancer. It is given as a solution through a catheter that is placed into the ureter or kidney. Jelmyto damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of alkylating agent.

Table 1. Record
IdentifierMLC-T-ONC-004580
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004580",
  "term": "Jelmyto",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient mitomycin, which comes from the bacterium Streptomyces, and is used to treat adults with a certain type of urothelial cancer. It is given as a solution through a catheter that is placed into the ureter or kidney. Jelmyto damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of alkylating agent.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/jelmyto/"
}

Record 9,689 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.